Small Molecules

28 Sep 2007 Study Shows Brostallicin in Combination with Cisplatin is Well-Tolerated and Produces Prolonged Disease Stabilization in Patients with Platinum-Resistant Cancers
28 Sep 2007 FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
28 Sep 2007 Pharmacopeia Confirms Blockade of Angiotensin II Response with First-In-Class PS433540 (DARA)
28 Sep 2007 AZOR(TM) Receives FDA Approval for Treatment of High Blood Pressure
28 Sep 2007 NKTR-102 (PEG-Irinotecan) Demonstrates Significant Anti-Tumor Activity and Improved Pharmacokinetic Profile in Preclinical Studies Presented at ECCO
28 Sep 2007 NeurogesX' NGX-4010 MAA Filed and Accepted for Review by EMEA for Treatment of Peripheral Neuropathic Pain
28 Sep 2007 Positive Clinical Data On MediciNova's Product Candidate MN-029 Presented At the 14th European Cancer Conference (ECCO 14)
28 Sep 2007 Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
27 Sep 2007 Ixabepilone in combination with capecitabine extends progression-free survival in metastatic breast cancer by 40% compared to capecitabine alone
27 Sep 2007 InterMune Announces Start of Phase 1b Trial of ITMN-191
27 Sep 2007 CombinatoRx Announces Initiation of Phase 2b Clinical Study of CRx-102 in Knee Osteoarthritis
27 Sep 2007 NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
27 Sep 2007 Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO)
27 Sep 2007 New Preliminary Phase II Data Show Anti-Tumor Activity of Single-Agent Sunitinib Malate in Advanced Gastric Cancer
27 Sep 2007 Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
27 Sep 2007 CollaGenex Pharmaceuticals Announces Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Rosacea
27 Sep 2007 Novacea Initiates Phase 2 Trial of Asentar in Advanced Pancreatic Cancer
27 Sep 2007 Recordati Successfully Ccompletes the Silodosin Double-Blind Phase III Study
27 Sep 2007 Alkermes and Indevus announce positive results form Phase 2a clinical study of Alks 27 for the treatment of COPD
27 Sep 2007 JT and Torii Sign Licensing Agreement with Keryx for Development and Commercialization of Hyperphosphatemia Drug in Japan
27 Sep 2007 ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
26 Sep 2007 Curis Provides Program Update on Development Candidate CUDC-101 and Its Targeted Cancer Drug Development Platform
26 Sep 2007 Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European College of Clinical Oncology Annual (ECCO) Meeting
26 Sep 2007 Orexigen(TM) Announces Positive Clinical Results of Its Proprietary Naltrexone Sustained Release Formulation for Use in Contrave(TM)
26 Sep 2007 Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up